EFFECTS OF THE CHRONIC TREATMENT WITH L-3,4-DIHYDROXYPHENYLALANINE (L-DOPA) ON THE NEUROENDOCRINE STRESS RESPONSE

ORRILLO SANTIAGO JORDI; IMSEN MERCEDES; LIZARRAGA ALFONSINA; ROMERO ANA CLARA; DE FINO FERNANDA; PEÑA MILAGROS; ABELEDO MACHADO ALEJANDRA; ZÁRATE SANDRA; FERRARIS JIMENA; DÍAZ-TORGA GRACIELA; PISERA DANIEL

Congreso; LIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; 2019

Stress evokes a complex response mediated by two systems: the hypothalamus-pituitary-adrenal (HPA) axis and the sympathetic-adreno-medullar (SAM) axis. Glucocorticoids and catecholamines secreted from the adrenal glands and sympathetic nerves are the main hormone effectors of the physiological adaptations observed during stress. Moreover, prolactin (PRL) is another pituitary hormone secreted under stressful stimuli. Catecholamines are synthesized from the hydroxylated precursor L-Dopa. This agent is also used with therapeutic purposes, e.g. in Parkinson?s disease. In the present research, we studied the effects of L-Dopa on the response to a stressor. Adult male Wistar rats (300 g) were chronically treated (24 days) with LEBOCAR (L-Dopa (75 mg/day) - Carbidopa (7.5 mg/day)) orally in drinking water and stressed by immobilization during the last 9 days of treatment. We first explored the activity of the SAM axis. Circulating noradrenaline increased in rats treated with LEBOCAR (p